John J. Kowalczyk, D.O., FACOS
, who was elected in February as the 55th president of the Osteopathic physicians and Surgeons of California, is both the first surgeon and the first urologist to hold this prestigious position. ACOS congratulates him on this accomplishment and commends him for his efforts to further the osteopathic surgical profession. Dr. Kowalczyk is a board certified urological surgeon at the Urology Group of Southern California, Lim-Keith Multispecialty Clinics, and Clinica Medica General, all in the Los Angeles area, and at Pacific Oaks Medical Group in Beverly Hills. He also serves as chair of the department of urology at Good Samaritan Hospital in Los Angeles, where he was named Physician of the Year in 2013. Throughout his career, he has been dedicated to resident and continuing medical education. He has helped prepare educational programming for the Annual Clinical Assembly of Osteopathic Surgeons as an ACOS program chair from 1997 to 2001 and currently for 2014–2015. He also is an expert reviewer for the Osteopathic Medical Board of California and served as a clinical professor of surgery at Midwestern University from 2012 to 2014. Dr. Kowalczyk is passionate about physician advocacy and patient safety. Elected in 2010 as a California delegate to the American Osteopathic Association House of Delegates, he has worked diligently to promote the interests of the osteopathic medical and surgical professions. He currently serves as chair of the Patient Safety Committee and the Clinical Practices Committee at Good Samaritan Hospital. He also serves on the board of directors for Good Samaritan IPA and the Physician Aide Association. Active in clinical investigation and research, he is affiliated with the American Institute of Research in Los Angeles—a research management organization of physicians and pharmaceutical companies that explore the future of medicine through clinical trials. Dr. Kowalczyk’s fields of interest include urodynamics, male impotence, male and female incontinence, sexual dysphoria, and prostate cancer.